Eureka BPO announces a trial launch of PHARDO system for NPO Petrovax Pharm LLC, Russia’s leading developer and manufacturer of innovative pharmaceuticals and vaccines. Within the project framework, the procedure of preparation and approval of registration dossier sections has been computerized and optimized to accelerate market launches of medicinal products.
Over the implementation period, the project stages have been completed as follows:
As a result of computerization of business processes, a regulatory documentation library will be formed that will become a shared resource for all process participants; the document drafting and approval time is expected to be reduced by 40%. Importantly, the creation of a unified dossier is a cross-functional process that involves different corporate units such as manufacturing, quality, medical, and regulatory. The system is used by more than 70 NPO Petrovax Pharm’s employees.
«The PHARDO system was implemented together with Eureka BPO in a short period, in less than 9 months. During the trial period, the registration dossier document approval processes will be tested and adjusted for medicinal product registration in Russia, the EAEU countries, and abroad pursuant to the requirements of their respective regulatory authorities and legislation. For our company, this is the first project involving computerization of marketing authorization processes», said NPO Petrovax Pharm President Elena Arkhangelskaya.
Presently, data migration is performed. The system transfer to productive operation is scheduled for May 2017.
PHARDO system’s major advantages are as follows: